Exclusive Online Content
CordenPharma Announces Completion of New Highly Potent API Process Bay for Category 4 Compounds
As part of a long term growth strategy designed to meet increasing customer demands, CordenPharma has completed a recent key investment to strengthen development and…
Catalent Biologics Announces Agreement With Moderna Therapeutics
Catalent Pharma Solutions, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced it has…
Global Market for Glycobiology to Reach Double Digit CAGRS in All Segments
New tools for synthesizing, modifying and studying oligosaccharides and glycoconjugates are charging the global glycobiology market. BCC Research reveals in its new report, Glycobiology: Global…
Cardiovascular Disease Market Set to Grow Very Slowly to $146.4 Billion
The cardiovascular disease market, which includes hypertension, dyslipidemia, and thrombotic events, is set to grow from $129.2 billion in 2015 to $146.4 billion by 2022,…
Gastrointestinal Drugs Market to Hit $48.4 Billion
The market size for gastrointestinal therapeutics is set to grow from $35.7 billion in 2015 to $48.4 billion by 2022, representing a compound annual growth…
Lupin Pharmaceutical Inc. & MonoSol Rx Enter Strategic Licensing Agreement to Develop Multiple Products
Lupin Pharmaceutical Inc., the US subsidiary of pharma major Lupin Limited (collectively Lupin) and MonoSol Rx, a specialty pharmaceutical company have entered into a strategic…
Biologics Candidate Manufactured Using Ajinomoto’s CORYNEX® Protein Expression System Enters Clinical Trials for the First Time
Ajinomoto Althea, Inc. (Althea) announced that a biologics candidate developed by a Japanese global pharmaceutical company and manufactured at Ajinomoto Althea using CORYNEX® Protein Expression…
Adare Pharmaceuticals Celebrates Corporate Headquarters Grand Opening
Adare Pharmaceuticals, a private global specialty pharmaceutical company, celebrated the official opening of its Corporate Headquarters located at 1200 Lenox Drive in Lawrenceville, New Jersey.…
"Engineering Medicines to Life" Campaign Highlights Capsugel's Unique Positioning as Specialty CDMO
After successfully completing four transformational acquisitions, as well as several other strategic investments, Capsugel today announced that it has unified them all under one brand…
Bristol-Myers Squibb & Nektar Therapeutics Announce Oncology Clinical Collaboration
Bristol-Myers Squibb Company and Nektar Therapeutics recently announced a new clinical collaboration to evaluate Bristol-Myers Squibb's Opdivo (nivolumab) with Nektar's investigational medicine, NKTR-214, as a…
Australian Pharmaceutical Market to Surpass $25 Billion
Australia’s pharmaceutical market is set to rise from just over $22.85 billion in 2016 to $25.2 billion by 2020, registering a compound annual growth rate…
Virtual Pharma Companies: The Future is Now
Virtual Pharma Companies: The Future is Now Virtual pharma companies are growing because the business model works. Experience and flexibility is key…
Amyris & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products
Amyris, Inc., the industrial bioscience company, recently announced that it has completed a subsequent collaboration agreement with Ginkgo Bioworks, which is expected to be approved…
Voyager Therapeutics Licenses Novel Gene Therapy Capsids From the California Institute of Technology
Voyager Therapeutics, Inc., a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), recently announced a co-exclusive worldwide…
Epizyme Earns $6-Million Milestone Payment From GlaxoSmithKline
Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapeutics, recently announced it has earned a $6 million milestone payment from GlaxoSmithKline (GSK). The milestone…
Gerresheimer to Sell Life Science Research Business
In line with its strategy of focusing on packaging and device solutions for pharmaceutical customers, Gerresheimer recently announced that it is to sell its Life…
Bayer Clinches Monsanto With Improved $66-Billion Bid
German drugs and crop chemicals company Bayer has won over US seeds firm Monsanto with an improved takeover offer of around $66 billion, ending months…
Niagara University Faculty Present Groundbreaking Research, New Insulin Pill For Diabetes Patients
NIAGARA UNIVERSITY, N.Y. - The need for painful insulin injections by certain diabetes patients may be eliminated with the introduction of a new technique…
Aptar Pharma Announces Development & License Agreement With BD
Aptar Pharma Announces Development & License Agreement With BD Aptar Pharma, a leading drug delivery solutions provider and segment of AptarGroup, Inc.…
CordenPharma Chenôve Receives Successful FDA Inspection
CordenPharma is pleased to announce that their CordenPharma Chenôve (France) manufacturing facility recently completed an FDA Inspection and received a successful response with no…
